CoChat

Neonatal levels of acute phase proteins and later risk of non-affective psychosis

Gardner, R M, Dalman, C, Wicks, S, Lee, B K, Karlsson, H · 2013 · Translational Psychiatry
Cited by 46

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/tp.2013.5

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 60

  1. Mortensen PB, Pedersen MG, Pedersen CB . Psychiatric family history and schizophrenia risk in Denmark: which mental disorders are relevant? Psychol Med 2010; 40: 201–210. · DOI · Paper page
  2. Torrey EF, Bartko JJ, Yolken RH . Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 2012; 38: 642–647. · DOI · Paper page
  3. Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O et al. Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med 1999; 340: 603–608. · DOI · Paper page
  4. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748–752. · DOI · Paper page
  5. Jia P, Wang L, Fanous AH, Chen X, Kendler KS, Zhao Z . A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. J Med Genet 2012; 49: 96–103. · DOI · Paper page
  6. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’er I et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753–757. · DOI · Paper page
  7. Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry, advance online publication, 22 May 2012; doi:10.1038/mp.2012.67. · DOI · Paper page
  8. Chen SJ, Chao YL, Chen CY, Chang CM, Wu EC, Wu CS et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry 2012; 200: 374–380. · DOI · Paper page
  9. van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 2008; 64: 820–822. · DOI · Paper page
  10. Brown AS, Cohen P, Greenwald S, Susser E . Nonaffective psychosis after prenatal exposure to rubella. Am J Psychiatry 2000; 157: 438–443. · DOI · Paper page
  11. Buka SL, Cannon TD, Torrey EF, Yolken RH . Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry 2008; 63: 809–815. · DOI · Paper page
  12. Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 2007; 61: 688–693. · DOI · Paper page
  13. Karlsson H, Blomstrom A, Wicks S, Yang S, Yolken RH, Dalman C . Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am J Psychiatry 2012; 169: 625–632. · DOI
  14. Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004; 161: 889–895. · DOI · Paper page
  15. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH . Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 2001; 15: 411–420. · DOI · Paper page
  16. Meyer U, Feldon J . Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 2010; 90: 285–326. · DOI · Paper page
  17. Hsiao EY, Patterson PH . Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 2011; 25: 604–615. · DOI · Paper page
  18. Gabay C, Kushner I . Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–454. · DOI · Paper page
  19. Bauer J, Lengyel G, Thung SN, Jonas U, Gerok W, Acs G . Human fetal hepatocytes respond to inflammatory mediators and excrete bile. Hepatology 1991; 13: 1131–1141. · DOI
  20. de Villiers WJ, Louw JP, Strachan AF, Etsebeth SM, Shephard EG, de Beer FC . C-reactive protein and serum amyloid A protein in pregnancy and labour. Br J Obstet Gynaecol 1990; 97: 725–730. · DOI
  21. Cannon M, Jones PB, Murray RM . Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 2002; 159: 1080–1092. · DOI · Paper page
  22. Fawzi MH, Fawzi MM, Fawzi MM, Said NS . C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia. Psychiat Res 2011; 190: 91–97. · DOI
  23. Fan X, Pristach C, Liu EY, Freudenreich O, Henderson DC, Goff DC . Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiat Res 2007; 149: 267–271. · DOI · Paper page
  24. Meyer JM, McEvoy JP, Davis VG, Goff DC, Nasrallah HA, Davis SM et al. Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Biol Psychiatry 2009; 66: 1013–1022. · DOI · Paper page
  25. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R . C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res 2007; 93: 261–265. · DOI · Paper page
  26. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R . Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia. Schizophr Res 2012; 134: 83–88. · DOI
  27. Wong CT, Tsoi WF, Saha N . Acute phase proteins in male Chinese schizophrenic patients in Singapore. Schizophr Res 1996; 22: 165–171. · DOI
  28. Chan MK, Guest PC, Levin Y, Umrania Y, Schwarz E, Bahn S et al. Converging evidence of blood-based biomarkers for schizophrenia: An update. Int Rev Neurobiol 2011; 101: 95–144. · DOI
  29. Inforzato A, Bottazzi B, Garlanda C, Valentino S, Mantovani A . Pentraxins in humoral innate immunity. Adv Exp Med Biol 2012; 946: 1–20. · DOI
  30. Becker KL, Nylen ES, White JC, Muller B, Snider RH . Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89: 1512–1525. · DOI · Paper page
  31. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM . Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4: 620–630. · DOI · Paper page
  32. Dalman C, Allebeck P, Gunnell D, Harrison G, Kristensson K, Lewis G et al. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry 2008; 165: 59–65. · DOI · Paper page
  33. Koponen H, Rantakallio P, Veijola J, Jones P, Jokelainen J, Isohanni M . Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004; 254: 9–13. · DOI
  34. Weiser M, Werbeloff N, Levine A, Livni G, Schreiber S, Halperin D et al. CNS infection in childhood does not confer risk for later schizophrenia: a case-control study. Schizophr Res 2010; 124: 231–235. · DOI
  35. Torrey EF, Yolken RH . Toxoplasma gondii and schizophrenia. Emerg Infect Dis 2003; 9: 1375–1380. · DOI · Paper page
  36. Niebuhr DW, Millikan AM, Cowan DN, Yolken R, Li Y, Weber NS . Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry 2008; 165: 99–106. · DOI · Paper page
  37. Pedersen MG, Stevens H, Pedersen CB, Norgaard-Pedersen B, Mortensen PB . Toxoplasma infection and later development of schizophrenia in mothers. Am J Psychiatry 2011; 168: 814–821. · DOI · Paper page
  38. Leweke FM, Gerth CW, Koethe D, Klosterkotter J, Ruslanova I, Krivogorsky B et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004; 254: 4–8. · DOI · Paper page
  39. Suzuki Y, Rani S, Liesenfeld O, Kojima T, Lim S, Nguyen TA et al. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect Immun 1997; 65: 2339–2345. · DOI · Paper page
  40. Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Muller M et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2010; 207: 1453–1464. · DOI · Paper page
  41. Gabay C . Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006; 8 (Suppl 2): S3. · DOI
  42. Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38: 611–618. · DOI · Paper page
  43. Teesalu T, Kulla A, Simisker A, Siren V, Lawrence DA, Assera T et al. Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost 2004; 92: 358–368. · DOI · Paper page
  44. de Boer JP, Creasey AA, Chang A, Abbink JJ, Roem D, Eerenberg AJ et al. Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model. Infect Immun 1993; 61: 5035–5043. · DOI
  45. Blomback B, Hessel B, Hogg D, Therkildsen L . A two-step fibrinogen--fibrin transition in blood coagulation. Nature 1978; 275: 501–505. · DOI · Paper page
  46. Masopust J, Maly R, Andrys C, Valis M, Bazant J, Hosak L . Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study. BMC psychiatry 2011; 11: 2. · DOI
  47. Friedman GC, Seeds NW . Tissue plasminogen activator expression in the embryonic nervous system. Brain Res Dev Brain Res 1994; 81: 41–49. · DOI
  48. Pothakos K, Robinson JK, Gravanis I, Marsteller DA, Dewey SL, Tsirka SE . Decreased serotonin levels associated with behavioral disinhibition in tissue plasminogen activator deficient (tPA-/-) mice. Brain Res 2010; 1326: 135–142. · DOI
  49. Buckley PF, Pillai A, Howell KR . Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry 2011; 24: 122–127. · DOI · Paper page
  50. Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H et al. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol 2010; 13: 535–539. · DOI · Paper page
  51. Siddappa AM, Rao R, Long JD, Widness JA, Georgieff MK . The assessment of newborn iron stores at birth: a review of the literature and standards for ferritin concentrations. Neonatology 2007; 92: 73–82. · DOI · Paper page
  52. Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 2010; 12: 293–304. · DOI · Paper page
  53. Insel BJ, Schaefer CA, McKeague IW, Susser ES, Brown AS . Maternal iron deficiency and the risk of schizophrenia in offspring. Arch Gen Psychiatry 2008; 65: 1136–1144. · DOI · Paper page
  54. Sorensen HJ, Nielsen PR, Pedersen CB, Mortensen PB . Association between prepartum maternal iron deficiency and offspring risk of schizophrenia: population-based cohort study with linkage of Danish national registers. Schizophr Bull 2011; 37: 982–987. · DOI
  55. Viteri FE . The consequences of iron deficiency and anemia in pregnancy. Adv Exp Med Biol 1994; 352: 127–139. · DOI
  56. Zornberg GL, Buka SL, Tsuang MT . Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am J Psychiatry 2000; 157: 196–202. · DOI · Paper page
  57. Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P . Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study. Br J Psychiatry 2001; 179: 403–408. · DOI · Paper page
  58. Aly H, Hamed Z, Mohsen L, Ramy N, Arnaoot H, Lotfy A . Serum amyloid A protein and hypoxic ischemic encephalopathy in the newborn. J Perinatol 2011; 31: 263–268. · DOI
  59. Ben Assayag E, Shenhar-Tsarfaty S, Bova I, Berliner S, Usher S, Peretz H et al. Association of the -757T>C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis. Thromb Res 2009; 124: 458–462. · DOI
  60. Lakoski SG, Li L, Langefeld CD, Liu Y, Howard TD, Brosnihan KB et al. The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study. Exp Mol Pathol 2007; 82: 280–283. · DOI

Cited by

Metadata

Authors
Gardner, R. M., Dalman, C., Wicks, S., Lee, B. K., & Karlsson, H.
Venue
Translational Psychiatry
Published
2013-02-19
Volume
3
Issue
2
Pages
e228-e228
ISSN
2158-3188
Cited by
46
References
11
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.